Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenocarcinoma Of Esophagus × spartalizumab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 von Hippel-Lindau Disease 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Solid Tumor, Adult 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1 Nasopharangeal Cancer 1 Myelodysplastic Syndromes 1 Melanoma 1 Locally Advanced Rectal Cancer 1 Leukemia, Myelomonocytic, Chronic 1 Kidney Neoplasms 1 Kidney Diseases 1 Hereditary leiomyomatosis and renal cell cancer 1 Glioma 1 Endometrial Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1 Colonic Neoplasms 1 Advanced Malignant Tumors 1 Advanced Malignant Solid Neoplasm 1

Interventions

Fluorouracil 10 Oxaliplatin 9 Nivolumab 9 Leucovorin 8 Capecitabine 7 pembrolizumab 4 Trastuzumab 4 Paclitaxel 4 Cisplatin 4 Specimen Handling 3 Irinotecan 3 Docetaxel 3 zimberelimab 2 zanidatamab 2 durvalumab 2 dehydroftorafur 2 Taxes 2 Radiotherapy 2 Radiation 2 Magnetic Resonance Spectroscopy 2 Endoscopy 2 Drug Therapy 2 Carboplatin 2 Biopsy 2 zolbetuximab 1 tucatinib 1 trifluridine tipiracil drug combination 1 tremelimumab 1 trastuzumab deruxtecan 1 trastuzumab biosimilar HLX02 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡